Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

State of the art: Atherosclerosis in a limited edition

Nature Medicine volume 4, pages 899–900 (1998)Cite this article

Two new mouse models closely mimic human atherosclerosis, providing exciting opportunities for elucidating the molecular mechanisms of this disease and for evaluating novel therapeutics (pages 934–938).

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Hennekens, C.H. Increasing burden of cardiovascular disease: Current knowledge and future directions for research on risk factors. Circulation 97, 1095–1102 (1998).

    Article  CAS  Google Scholar 

  2. Gould, L.A., Rossouw, J.E., Santanello, N.C., Heyse, J.F. & Furberg, C.D. Cholesterol reduction yields clinical benefit: Impact of statin trials. Circulation 97, 946–952 (1998).

    Article  CAS  Google Scholar 

  3. Powell-Braxton, L.M. et al. A mouse model of human familial hypercholesterolemia: Markedly elevated low density lipoprotein cholesterol levels and severe atherosclerosis on a low-fat, chow diet. Nature Med. 4, 934–938 (1998).

    Article  CAS  Google Scholar 

  4. Sanan, D.A. et al. Low density lipoprotein receptor-negative mice expressing human apolipoprotein B-100 develop complex atherosclerotic lesions on a chow diet: No accentuation by apolipoprotein (a). Proc. Natl. Acad. Sci. USA 95, 4544–4549 (1998).

    Article  CAS  Google Scholar 

  5. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. & William, R.A. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 68, 231–240 (1987).

    Article  CAS  Google Scholar 

  6. Breslow, J.L. Mouse models of atherosclerosis. Science 272, 685–688 (1996).

    Article  CAS  Google Scholar 

  7. Plump, A.S. et al. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71, 343–353 (1992).

    Article  CAS  Google Scholar 

  8. Zhang, S., Reddick, R., Piedrahita, J. & Maeda, N. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258, 468–471 (1992).

    Article  CAS  Google Scholar 

  9. Nakashima, Y., Plump, A.S., Raines, E.W., Breslow, J.L. & Ross, R. ApoE-deficient mice develop lesions in all phases of atherosclerosis throughout the arterial tree. Arteriosclerosis and Thrombosis 14, 133–140 (1994).

    Article  CAS  Google Scholar 

  10. Ishibashi, S., Goldstein, J., Brown, M., Herz, J. & Burns, D. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93, 1885–1893 (1994).

    Article  CAS  Google Scholar 

  11. Tangirala, R.K., Rubin, E.M. & Palinski, W. Quantitation of atherosclerosis in murine models: Correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between the sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36, 2320–2328 (1995).

    CAS  PubMed  Google Scholar 

  12. Davidson, N.O., Anant, S. & MacGinnitie, A.J. Apolipoprotein B messenger RNA editing: Insights into the molecular regulation of post-transcrip-tional cytidine deamination. Curr Opin Lipidol 6, 70–74 (1995).

    Article  CAS  Google Scholar 

  13. Rohlmann, A., Gotthardt, M., Hammer, R.E. & Herz, J. Inducible inactivation of hepatic LRP gene by cre-mediated recombination confirms role of LRP in clearance of chylomicron remnants. J. Clin. Invest. 101, 689–695 (1998).

    Article  CAS  Google Scholar 

  14. Hirano, K. et al. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B-48. Biol Chem. 271, 9887–9890 (1996).

    Article  CAS  Google Scholar 

  15. Farese, R.V. et al. Phenotypic analysis of mice expressing exclusively apolipoprotein B-48 or apolipoprotein B-100. Proc. Natl. Acad. Sci. USA 93, 6393–6398 (1996).

    Article  CAS  Google Scholar 

  16. Kim, E. & Young, S.G. Genetically modified mice for the study of apolipoprotein B. J. Lipid Res. 39, 703–723 (1998).

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Experimental Therapeutics and Departments of Pharmacology and Medicine, University of Pennsylvania Health System, Philadelphia, Pennsylvania, 19104, USA

    Daniel J. Rader & Garret A. FitzGerald

Authors
  1. Daniel J. Rader
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Garret A. FitzGerald
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Rader, D., FitzGerald, G. State of the art: Atherosclerosis in a limited edition. Nat Med 4, 899–900 (1998). https://doi.org/10.1038/nm0898-899

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0898-899

This article is cited by

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing